Search
29/01/2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
Bolsewig, K, Willemse, EAJ, Sánchez-Juan, P, Rábano, A, Martínez, M, Doecke, JD, Bellomo, G, Vermunt, L, Alcolea, D, Halbgebauer, S, 't Veld, SI, Mattsson-Carlgren, N, Veverova, K, Fowler, CJ, Boonkamp, L, Koel-Simmelink, M, Hussainali, Z, Ruiters, DN, Gaetani, L, Toja, A, Fortea, J, Pijnenburg, Y, Lemstra, AW, van der Flier, WM, Hort, J, Otto, M, Hansson, O, Parnetti, L, Masters, CL, Lleó, A, Teunissen, CE, Milán, MD. Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-56293-z. PMID:39881147. IF:15.700(Q1/1D).
29/01/2025
Inter-Laboratory Validation of Nodal/Paranodal Antibody Testing
Lleixà, C, Titulaer, M, Rohrbacher, S, Mgbachi, V, Halstead, S, Fehmi, J, Pascual-Goñi, E, Zhu, L, Appeltshauser, L, Franken, S, Paunovic, M, Waters, P, Willison, H, Sommer, C, Querol, L, Huizinga, R, Doppler, K, Rinaldi, S. Inter-Laboratory Validation of Nodal/Paranodal Antibody Testing. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(1)DOI:10.1111/jns.70000. PMID:39887819. IF:3.200(Q2/4D).
29/01/2025
Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project
Hernández-Rodríguez, J, Martínez-Valle, F, Acebes, X, Alerany, C, Antón, J, Calvo, G, Corral, M, Cruz, J, Mangues-Bafalluy, MA, Mateo, J, Rivera, J, Salazar, A, Francisco, R, Mallol, C, Reig-Viader, R, Tigri-Santiña, A, Ricart, A, Palau, F. Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03518-x. PMID:39875900. IF:3.500(Q2/4D).
27/01/2025
Therapeutic alliance in a stepped digital psychosocial intervention for breast cancer patients: findings from a multicentre randomised controlled trial
Flix-Valle, A, Medina, JC, Souto-Sampera, A, Arizu-Onassis, A, Juan-Linares, E, Serra-Blasco, M, Ciria-Suárez, L, Feixas, G, Ochoa-Arnedo, C. Therapeutic alliance in a stepped digital psychosocial intervention for breast cancer patients: findings from a multicentre randomised controlled trial. BJPsych Open. 2025; 11(1)DOI:10.1192/bjo.2024.844. PMID:39865983. IF:3.500(Q1/3D).
23/01/2025
Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis
Alvarez-Sánchez, E, Carbayo, A, Valle-Tamayo, N, Muñoz, L, Aumatell, J, Torres, S, Rubio-Guerra, S, García-Castro, J, Selma-González, J, Alcolea, D, Turon-Sans, J, Lleo, A, Illán-Gala, I, Fortea, J, Rojas-García, R, Dols-Icardo, O. Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis. Journal of Neuroinflammation. 2025; 22(1)DOI:10.1186/s12974-025-03347-0. PMID:39849490. IF:10.100(Q1/1D).
22/01/2025
Vascraft: new decellularized and re-endothelialized human vascular graft produced by tissue engineering for use in arterial bypass
Picornell, GI, Gálvez-Montón, C, Onetti, Y, Martorell, J, López-Puerto, L, Savio, A, Castells-Sala, C, Guijosa, CM. Vascraft: new decellularized and re-endothelialized human vascular graft produced by tissue engineering for use in arterial bypass. BJS-BRITISH JOURNAL OF SURGERY. 2025; 112DOI:10.1093/bjs/znae322.011. PMID:. IF:8.800(Q1/1D).